Abstract Objective To investigate the female sexual dysfunction （FSD） in type 2 diabetes patients, by comparing the sexual function between type 2 diabetic women and non-diabetic women with Female Sexual Function In...Abstract Objective To investigate the female sexual dysfunction （FSD） in type 2 diabetes patients, by comparing the sexual function between type 2 diabetic women and non-diabetic women with Female Sexual Function Index （FSFI）. Methods 215 type 2 diabetic women and 107 age-matched non-diabetes women were enrolled with similar backgrounds. Their sexual functions were evaluated with FSFI. Metabolic parameters such as body mass index, blood lipid profile, hemoglobin AlC, plasma glucose were also collected. Results Total score of FSFI of the type 2 diabetic women were significantly lower than that of the non-diabetic controls （18.27±8.96 vs. 23.02±5.78, P=0.000）. Scores of the FSFI domains （desire, arousal, lubrication, orgasm, satisfaction, pain） of the type 2 diabetic group were also lower than those of the control group. According to the FSD criterion （FSFI〈25） available in China, the percentage of FSD in the type 2 diabetic group was significantly higher than that of the control group （79.2% vs. 55.0%, P〈0.001）. These trends seemed more prominent in pre-menopause subgroups. The logistic regression analysis indicated that age and diabetes were independent risk factors of FSD. Body Mass Index （BMI） also had influence in the diabetes group. Conclusion Findings from this study showed that there are more FDS in Chinese type 2 diabetic women than in their non-diabetic counterparts, especially in pre-menopause participants.展开更多
目的 了解南宁市成年女性的性健康、性功能障碍（female sexual dysfunction,FSD）状况及其主要影响因素,为女性性健康的宣教、政策的制订及FSD的防治提供参考。方法 使用中文版女性性功能量表（Chinese version of Female Sexual Funct...目的 了解南宁市成年女性的性健康、性功能障碍（female sexual dysfunction,FSD）状况及其主要影响因素,为女性性健康的宣教、政策的制订及FSD的防治提供参考。方法 使用中文版女性性功能量表（Chinese version of Female Sexual Function Index,CV-FSFI）对2011年3月至2012年3月在广西壮族自治区妇幼保健院进行健康体检的南宁市661名健康中青年女性或女性陪伴者进行性功能状况的问卷调查,年龄20~43岁,平均年龄（27.61±6.23）岁,其中汉族383名,壮族267名,其他民族11名,以FSFI总评分〈25分作为FSD的诊断标准,各单项评分小于该单项的均数作为诊断各类型性功能障碍的标准。结果 本组女性的FSFI总评分为（24.29±3.56）分,FSD总体发生率为52.50%（347/661）,各种性功能障碍的发生率高低依次为性满足感下降68.53%（453/661）、性高潮障碍47.05%（311/661）、性唤起障碍35.70%（236/661）、性交痛33.13%（219/661）、阴道润滑不足29.65%（196/661）、性欲望降低25.87%（171/661）。随着年龄增长,FSFI评分及各单项评分逐渐下降。教育程度越高、职业越好,性满足感越高。结论 南宁市成年女性的性健康状况不容乐观,FSD总发生率高,并受年龄、职业、教育程度及婚姻状况等因素的影响。展开更多
目的调查不同生殖衰老分期女性性功能障碍(female sexual dysfunction,FSD)以及应用激素替代治疗(hormone replace therapy,HRT)的绝经后女性FSD的现状。方法本研究为多中心临床研究,纳入2019年6月至2020年8月在首都医科大学附属北京妇...目的调查不同生殖衰老分期女性性功能障碍(female sexual dysfunction,FSD)以及应用激素替代治疗(hormone replace therapy,HRT)的绝经后女性FSD的现状。方法本研究为多中心临床研究,纳入2019年6月至2020年8月在首都医科大学附属北京妇产医院及两家医联体医疗机构就诊且符合纳入和排除标准的女性902例。根据生殖衰老分期(Stages of Reproductive Aging Workshop,STRAW+10)及绝经后女性是否应用激素替代治疗(hormone replace therapy,HRT),将研究对象分为7组:生育期组(reproductive group,R)146例、绝经过渡期早期组(early menopausal transition group,ET)199例,绝经过渡期晚期组(late menopausal transition group,LT)87例,绝经后早期组(early postmenopause group,EP)183例,绝经后晚期组(late postmenopause group,LP)41例,绝经后早期应用HRT组(early postmenopausal women using HRT,EP-HRT)207例应用雌二醇片2 mg/雌二醇地屈孕酮片(2 mg:10 mg),绝经后晚期应用HRT组(late postmenopausal women using HRT,LP-HRT)39例应用雌二醇屈螺酮片(1 mg:2 mg)。女性性功能指数(Female Sexual Function Index,FSFI)量表评估FSD。结果EP组和LP组的FSD、性欲障碍、阴道润滑障碍、性满意度障碍以及性交痛的比例均明显高于R组、ET组和LT组,LP组性唤起障碍和性高潮障碍的比例、EP组性唤起障碍的比例高于R组、ET组,LT组性欲障碍和性唤起障碍的比例、EP组性高潮障碍的比例高于R组,LP组的阴道润滑障碍和性交痛的比例均高于EP组(P<0.05)。EP-HRT组的FSD、性欲障碍和性满意度障碍的比例明显低于EP组(P<0.05)。LP-HRT组的阴道润滑障碍、性满意度障碍以及性交痛的比例明显低于LP组(P<0.05)。结论女性FSD的比例随生殖衰老分期的提高而显著升高,应用HRT可降低绝经后女性FSD的比例。展开更多
目的评估口服避孕药(oral contraceptives,OCs)对多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者性功能的影响,并分析其女性性功能障碍(female sexual dysfunction,FSD)发生的危险因素。方法研究共纳入210例门诊PCOS患者,其中服...目的评估口服避孕药(oral contraceptives,OCs)对多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者性功能的影响,并分析其女性性功能障碍(female sexual dysfunction,FSD)发生的危险因素。方法研究共纳入210例门诊PCOS患者,其中服用口服避孕药者126例(OC组),未服用者84例(NOC组)。采用网络女性性功能指数(Female Sexual Function Index,FSFI)量表,并补充附加问题,评估参与者的基本信息、避孕方法、性伴侣关系稳定程度、孕产史等多个女性性功能的潜在影响因素。结果OC组FSFI总分中位数为26.35分,50.79%表现为FSD高风险;NOC组FSFI总分中位数26.85分,47.62%显示FSD高风险;两组得分相比差异无统计学意义(P=0.635)。在口服避孕药使用者中,服用35μg炔雌醇/2 mg醋酸环丙孕酮、30μg炔雌醇/3mg屈螺酮、30μg炔雌醇/150μg去氧孕烯三种不同成分口服避孕药的患者之间,FSFI得分差异无统计学意义。经Logistic回归分析,性生活是否主动、伴侣关系是否稳定是PCOS患者性功能的影响因素。结论 PCOS患者中,是否服用口服避孕药、服用不同类型口服避孕药的患者之间性功能评分差异均无统计学意义。PCOS患者性功能的潜在影响因素中,性生活是否主动、伴侣关系是否稳定与FSD高风险的发生相关。展开更多
目的:了解宫颈疾病女性性功能障碍(female sexual dysfunction,FSD)患病率及危险因素。方法:采用回顾性调查方法,对在南京医科大学附属南京妇幼保健院宫颈科门诊就诊的18-55岁有正常性生活女性进行问卷调查。取宫颈脱落细胞,采用PCR和...目的:了解宫颈疾病女性性功能障碍(female sexual dysfunction,FSD)患病率及危险因素。方法:采用回顾性调查方法,对在南京医科大学附属南京妇幼保健院宫颈科门诊就诊的18-55岁有正常性生活女性进行问卷调查。取宫颈脱落细胞,采用PCR和膜杂交方法,检测出21种常见人乳头瘤病毒(human papillomavirus,HPV)中任何一种HPV亚型即为HPV阳性。通过宫颈专科医生常规妇科检查获知女性所患宫颈疾病。应用女性性功能指数(female sexual function index,FSFI)问卷对受访者近1个月的性生活状况进行调查,采用多因素非条件Logistic回归分析影响FSD的宫颈疾病。结果:发放调查问卷共2 045份,472例拒绝,1 573例接受问卷调查,去除不合格问卷458份,有效问卷1 115份,有效率71%。1 115例女性研究对象中宫颈疾病患者占43.6%(486/1 115)。486例宫颈疾病患者中,性功能障碍者占52.3%(254/486)。在FSD组中,患有宫颈疾病者显著多于宫颈正常者,差异有统计学意义(P<0.01)。宫颈疾病组的性欲、性唤起、阴道润滑、性高潮、性满意、性疼痛等各项性功能评分值均低于宫颈正常组(P<0.05)。多因素非条件Logistic回归分析表明:宫颈息肉(OR=1.57,95%CI=1.01-2.45)、宫颈糜烂(OR=1.74,95%CI=1.23-2.45)、宫颈肥大(OR=2.26,95%CI=1.33-3.84)、宫颈上皮内瘤变(cervicalintraepithelialneoplasia,CIN)(OR=2.95,95%CI=2.13-4.08)是FSD的独立危险因素。危险度大小依次是:CIN>宫颈肥大>宫颈糜烂>宫颈息肉。结论:南京城区FSD在宫颈疾病专科门诊中发病率颇高,有必要加强性保健宣传,促使有宫颈疾病者定期进行生殖系统健康体检,形成良好的性生活方式,从而降低FSD发病率。展开更多
目的目前,影响女性性功能的各种病因已经被广泛研究,但是输尿管肾镜手术对女性性功能障碍的影响尚不清楚。本研究旨在探讨输尿管肾镜术后留置JJ管对女性性功能的影响。方法采用前瞻性研究,前瞻性选取2014年9月至2017年11月苏州大学附属...目的目前,影响女性性功能的各种病因已经被广泛研究,但是输尿管肾镜手术对女性性功能障碍的影响尚不清楚。本研究旨在探讨输尿管肾镜术后留置JJ管对女性性功能的影响。方法采用前瞻性研究,前瞻性选取2014年9月至2017年11月苏州大学附属第一医院和盐城市中医院诊治的年龄大于22岁有规律性生活的确诊输尿管结石的已婚中青年女性患者67例作为研究对象。根据患者结石负荷、是否为孤立肾、术中输尿管损伤或输尿管梗阻严重影响肾功能等情况选择是否术后放置JJ管。67例患者分为两组:研究组35例,行输尿管镜碎石术与JJ管置入术;对照组32例,行输尿管镜取石术术后不留置JJ管。术前、术后第一个月和第三个月使用女性性功能指数(female sexual function index,FSFI)评估性功能。记录和评估患者的总体满意度、年龄、手术时间、支架留置时间、体重指数(body mass index,BMI)、结石负荷、月收入状况、受教育程度和心理状态等临床资料。结果两组患者年龄、BMI、住院时间、月收入状况和受教育程度比较,其差异均无统计学意义(均P>0.05);两组患者结石负荷比较,差异具有统计学意义(P<0.05)。研究组和对照组术前FSFI总评分分别为(22.2±0.86)、(24±0.71);术后第一月FSFI总评分分别为(13±0.71)、(23.4±0.98);术后第三月FSFI总评分分别为(22.6±0.81)、(22.2±1.32)。术前和术后第三个月FSFI总评分,两组间比较差异无统计学意义(P>0.05);术后第一月FSFI总评分,两组间比较差异有统计学意义(P<0.05)。在术后第一月FSFI 6个具体领域方面,研究组的主观性唤起能力、性高潮和性生活满意度下降,性交痛增加,这四个领域与对照组分别比较,差异具有统计学意义(P<0.05);在性欲、性活动时阴道润滑度两个领域,两组间比较差异无统计学意义(P>0.05)。研究组术前、术后第一月、术后第三月的性功能障碍发展开更多
Background: Sexual dysfunction is sexual complaints or disorders. There are various causes, but the onset leads to deterioration of relationships and quality of life with partners. There is still a deep-rooted awarene...Background: Sexual dysfunction is sexual complaints or disorders. There are various causes, but the onset leads to deterioration of relationships and quality of life with partners. There is still a deep-rooted awareness that sexuality is a secret in Japan. Aim: This study aims to clarify the relationship between female sexual function and depression or anxiety. Method: Four hundred and fifty-eight Japanese healthy women who worked in four randomly selected medical institutions in Okinawa Prefecture in Japan from March to May 2012 were asked to agree to a consent form of their own free will and participate in self-reported questionnaires. For their evaluation, the Female Sexual Function Index (FSFI;Rosen et al. 2000, which includes the six domains of desire, arousal, lubrication, orgasm, pain, and satisfaction) and the Kessler Psychological Distress Scale (K6;Kessler, 2002, which includes the following six items: felt nervous, hopeless, restless or fidgety, worthless, depressed, and felt that everything was an effort) was used. Moreover, participants’ characteristics showed age, marriage, menopause, annual income, and drinking. In addition, JMP16.2 and R 4.2.0 was used to perform Pearson’s chi-square test, Fisher’s exact test, Mann-Whitney U test, Kruskal-Wallis test, Steel-Dwass test, Spearman’s Rank-Order Correlation, and Cronbach’s alpha. This study was approved by the university and the medical institutional review board (IRB). Results: 178 women were included in the final analysis, and the median (IQR, interquartile range) was 39 (32 - 48) years old, and the mean ± SD (standard deviation) was 40.2 ± 10.4 years old. The median (IQR) and mean ± SD of FSFI Total Score were 22.0 (9.3 - 26.6) and 19.2 ± 9.6. The median (IQR) and the mean ± SD of K6 Total Score were 3 (0 - 7) and 4.2 ± 4.5. 16% of all women with a K6 Total Score of 10 and more, and 5% of all women with a K6 Total Score of 13 and more considered a serious mental illness. There was no clear association between female sexual function a展开更多
基金supported by the Research Fund from Zhejiang Health Department,2009A119
文摘Abstract Objective To investigate the female sexual dysfunction （FSD） in type 2 diabetes patients, by comparing the sexual function between type 2 diabetic women and non-diabetic women with Female Sexual Function Index （FSFI）. Methods 215 type 2 diabetic women and 107 age-matched non-diabetes women were enrolled with similar backgrounds. Their sexual functions were evaluated with FSFI. Metabolic parameters such as body mass index, blood lipid profile, hemoglobin AlC, plasma glucose were also collected. Results Total score of FSFI of the type 2 diabetic women were significantly lower than that of the non-diabetic controls （18.27±8.96 vs. 23.02±5.78, P=0.000）. Scores of the FSFI domains （desire, arousal, lubrication, orgasm, satisfaction, pain） of the type 2 diabetic group were also lower than those of the control group. According to the FSD criterion （FSFI〈25） available in China, the percentage of FSD in the type 2 diabetic group was significantly higher than that of the control group （79.2% vs. 55.0%, P〈0.001）. These trends seemed more prominent in pre-menopause subgroups. The logistic regression analysis indicated that age and diabetes were independent risk factors of FSD. Body Mass Index （BMI） also had influence in the diabetes group. Conclusion Findings from this study showed that there are more FDS in Chinese type 2 diabetic women than in their non-diabetic counterparts, especially in pre-menopause participants.
文摘目的 了解南宁市成年女性的性健康、性功能障碍（female sexual dysfunction,FSD）状况及其主要影响因素,为女性性健康的宣教、政策的制订及FSD的防治提供参考。方法 使用中文版女性性功能量表（Chinese version of Female Sexual Function Index,CV-FSFI）对2011年3月至2012年3月在广西壮族自治区妇幼保健院进行健康体检的南宁市661名健康中青年女性或女性陪伴者进行性功能状况的问卷调查,年龄20~43岁,平均年龄（27.61±6.23）岁,其中汉族383名,壮族267名,其他民族11名,以FSFI总评分〈25分作为FSD的诊断标准,各单项评分小于该单项的均数作为诊断各类型性功能障碍的标准。结果 本组女性的FSFI总评分为（24.29±3.56）分,FSD总体发生率为52.50%（347/661）,各种性功能障碍的发生率高低依次为性满足感下降68.53%（453/661）、性高潮障碍47.05%（311/661）、性唤起障碍35.70%（236/661）、性交痛33.13%（219/661）、阴道润滑不足29.65%（196/661）、性欲望降低25.87%（171/661）。随着年龄增长,FSFI评分及各单项评分逐渐下降。教育程度越高、职业越好,性满足感越高。结论 南宁市成年女性的性健康状况不容乐观,FSD总发生率高,并受年龄、职业、教育程度及婚姻状况等因素的影响。
文摘目的调查不同生殖衰老分期女性性功能障碍(female sexual dysfunction,FSD)以及应用激素替代治疗(hormone replace therapy,HRT)的绝经后女性FSD的现状。方法本研究为多中心临床研究,纳入2019年6月至2020年8月在首都医科大学附属北京妇产医院及两家医联体医疗机构就诊且符合纳入和排除标准的女性902例。根据生殖衰老分期(Stages of Reproductive Aging Workshop,STRAW+10)及绝经后女性是否应用激素替代治疗(hormone replace therapy,HRT),将研究对象分为7组:生育期组(reproductive group,R)146例、绝经过渡期早期组(early menopausal transition group,ET)199例,绝经过渡期晚期组(late menopausal transition group,LT)87例,绝经后早期组(early postmenopause group,EP)183例,绝经后晚期组(late postmenopause group,LP)41例,绝经后早期应用HRT组(early postmenopausal women using HRT,EP-HRT)207例应用雌二醇片2 mg/雌二醇地屈孕酮片(2 mg:10 mg),绝经后晚期应用HRT组(late postmenopausal women using HRT,LP-HRT)39例应用雌二醇屈螺酮片(1 mg:2 mg)。女性性功能指数(Female Sexual Function Index,FSFI)量表评估FSD。结果EP组和LP组的FSD、性欲障碍、阴道润滑障碍、性满意度障碍以及性交痛的比例均明显高于R组、ET组和LT组,LP组性唤起障碍和性高潮障碍的比例、EP组性唤起障碍的比例高于R组、ET组,LT组性欲障碍和性唤起障碍的比例、EP组性高潮障碍的比例高于R组,LP组的阴道润滑障碍和性交痛的比例均高于EP组(P<0.05)。EP-HRT组的FSD、性欲障碍和性满意度障碍的比例明显低于EP组(P<0.05)。LP-HRT组的阴道润滑障碍、性满意度障碍以及性交痛的比例明显低于LP组(P<0.05)。结论女性FSD的比例随生殖衰老分期的提高而显著升高,应用HRT可降低绝经后女性FSD的比例。
文摘目的评估口服避孕药(oral contraceptives,OCs)对多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者性功能的影响,并分析其女性性功能障碍(female sexual dysfunction,FSD)发生的危险因素。方法研究共纳入210例门诊PCOS患者,其中服用口服避孕药者126例(OC组),未服用者84例(NOC组)。采用网络女性性功能指数(Female Sexual Function Index,FSFI)量表,并补充附加问题,评估参与者的基本信息、避孕方法、性伴侣关系稳定程度、孕产史等多个女性性功能的潜在影响因素。结果OC组FSFI总分中位数为26.35分,50.79%表现为FSD高风险;NOC组FSFI总分中位数26.85分,47.62%显示FSD高风险;两组得分相比差异无统计学意义(P=0.635)。在口服避孕药使用者中,服用35μg炔雌醇/2 mg醋酸环丙孕酮、30μg炔雌醇/3mg屈螺酮、30μg炔雌醇/150μg去氧孕烯三种不同成分口服避孕药的患者之间,FSFI得分差异无统计学意义。经Logistic回归分析,性生活是否主动、伴侣关系是否稳定是PCOS患者性功能的影响因素。结论 PCOS患者中,是否服用口服避孕药、服用不同类型口服避孕药的患者之间性功能评分差异均无统计学意义。PCOS患者性功能的潜在影响因素中,性生活是否主动、伴侣关系是否稳定与FSD高风险的发生相关。
文摘目的:了解宫颈疾病女性性功能障碍(female sexual dysfunction,FSD)患病率及危险因素。方法:采用回顾性调查方法,对在南京医科大学附属南京妇幼保健院宫颈科门诊就诊的18-55岁有正常性生活女性进行问卷调查。取宫颈脱落细胞,采用PCR和膜杂交方法,检测出21种常见人乳头瘤病毒(human papillomavirus,HPV)中任何一种HPV亚型即为HPV阳性。通过宫颈专科医生常规妇科检查获知女性所患宫颈疾病。应用女性性功能指数(female sexual function index,FSFI)问卷对受访者近1个月的性生活状况进行调查,采用多因素非条件Logistic回归分析影响FSD的宫颈疾病。结果:发放调查问卷共2 045份,472例拒绝,1 573例接受问卷调查,去除不合格问卷458份,有效问卷1 115份,有效率71%。1 115例女性研究对象中宫颈疾病患者占43.6%(486/1 115)。486例宫颈疾病患者中,性功能障碍者占52.3%(254/486)。在FSD组中,患有宫颈疾病者显著多于宫颈正常者,差异有统计学意义(P<0.01)。宫颈疾病组的性欲、性唤起、阴道润滑、性高潮、性满意、性疼痛等各项性功能评分值均低于宫颈正常组(P<0.05)。多因素非条件Logistic回归分析表明:宫颈息肉(OR=1.57,95%CI=1.01-2.45)、宫颈糜烂(OR=1.74,95%CI=1.23-2.45)、宫颈肥大(OR=2.26,95%CI=1.33-3.84)、宫颈上皮内瘤变(cervicalintraepithelialneoplasia,CIN)(OR=2.95,95%CI=2.13-4.08)是FSD的独立危险因素。危险度大小依次是:CIN>宫颈肥大>宫颈糜烂>宫颈息肉。结论:南京城区FSD在宫颈疾病专科门诊中发病率颇高,有必要加强性保健宣传,促使有宫颈疾病者定期进行生殖系统健康体检,形成良好的性生活方式,从而降低FSD发病率。
文摘目的目前,影响女性性功能的各种病因已经被广泛研究,但是输尿管肾镜手术对女性性功能障碍的影响尚不清楚。本研究旨在探讨输尿管肾镜术后留置JJ管对女性性功能的影响。方法采用前瞻性研究,前瞻性选取2014年9月至2017年11月苏州大学附属第一医院和盐城市中医院诊治的年龄大于22岁有规律性生活的确诊输尿管结石的已婚中青年女性患者67例作为研究对象。根据患者结石负荷、是否为孤立肾、术中输尿管损伤或输尿管梗阻严重影响肾功能等情况选择是否术后放置JJ管。67例患者分为两组:研究组35例,行输尿管镜碎石术与JJ管置入术;对照组32例,行输尿管镜取石术术后不留置JJ管。术前、术后第一个月和第三个月使用女性性功能指数(female sexual function index,FSFI)评估性功能。记录和评估患者的总体满意度、年龄、手术时间、支架留置时间、体重指数(body mass index,BMI)、结石负荷、月收入状况、受教育程度和心理状态等临床资料。结果两组患者年龄、BMI、住院时间、月收入状况和受教育程度比较,其差异均无统计学意义(均P>0.05);两组患者结石负荷比较,差异具有统计学意义(P<0.05)。研究组和对照组术前FSFI总评分分别为(22.2±0.86)、(24±0.71);术后第一月FSFI总评分分别为(13±0.71)、(23.4±0.98);术后第三月FSFI总评分分别为(22.6±0.81)、(22.2±1.32)。术前和术后第三个月FSFI总评分,两组间比较差异无统计学意义(P>0.05);术后第一月FSFI总评分,两组间比较差异有统计学意义(P<0.05)。在术后第一月FSFI 6个具体领域方面,研究组的主观性唤起能力、性高潮和性生活满意度下降,性交痛增加,这四个领域与对照组分别比较,差异具有统计学意义(P<0.05);在性欲、性活动时阴道润滑度两个领域,两组间比较差异无统计学意义(P>0.05)。研究组术前、术后第一月、术后第三月的性功能障碍发
文摘Background: Sexual dysfunction is sexual complaints or disorders. There are various causes, but the onset leads to deterioration of relationships and quality of life with partners. There is still a deep-rooted awareness that sexuality is a secret in Japan. Aim: This study aims to clarify the relationship between female sexual function and depression or anxiety. Method: Four hundred and fifty-eight Japanese healthy women who worked in four randomly selected medical institutions in Okinawa Prefecture in Japan from March to May 2012 were asked to agree to a consent form of their own free will and participate in self-reported questionnaires. For their evaluation, the Female Sexual Function Index (FSFI;Rosen et al. 2000, which includes the six domains of desire, arousal, lubrication, orgasm, pain, and satisfaction) and the Kessler Psychological Distress Scale (K6;Kessler, 2002, which includes the following six items: felt nervous, hopeless, restless or fidgety, worthless, depressed, and felt that everything was an effort) was used. Moreover, participants’ characteristics showed age, marriage, menopause, annual income, and drinking. In addition, JMP16.2 and R 4.2.0 was used to perform Pearson’s chi-square test, Fisher’s exact test, Mann-Whitney U test, Kruskal-Wallis test, Steel-Dwass test, Spearman’s Rank-Order Correlation, and Cronbach’s alpha. This study was approved by the university and the medical institutional review board (IRB). Results: 178 women were included in the final analysis, and the median (IQR, interquartile range) was 39 (32 - 48) years old, and the mean ± SD (standard deviation) was 40.2 ± 10.4 years old. The median (IQR) and mean ± SD of FSFI Total Score were 22.0 (9.3 - 26.6) and 19.2 ± 9.6. The median (IQR) and the mean ± SD of K6 Total Score were 3 (0 - 7) and 4.2 ± 4.5. 16% of all women with a K6 Total Score of 10 and more, and 5% of all women with a K6 Total Score of 13 and more considered a serious mental illness. There was no clear association between female sexual function a
